Fenja and Malin start their 3-month PharMetrX Industry Module 2 (I2) in Denmark
On 01 February. Our Research+ PhD student Fenja Klima and Training+ PhD student Malin Andersson are joining the pharmacometric group Novo Nordisk, one of our PharMetrX Industry Partner Consortium.
Our Research+ PhD student Johannes is currently completing a 3-month PharMetrX Industry Module 2
Until November 30, Johannes Tillil is taking the opportunity to gain first-hand insights and experience in M&S/pharmacometrics groups at our industry partner Merck as part of his internship.
Malin Andersson, Fenja Klima and Zrinka Duvnjak on symposium trip to Gothenburg, Sweden
On 11th and 12th of November 2024 the AstraZeneca Young career symposium on Pharmacokinetics & Pharmacodynamics in Drug Discovery & Development took place at AstraZeneca, Gothenburg, Sweden.
New insights into cortisol replacement therapy optimization - our latest publication by Davide Bindellini et al. in July. Model-informed precision dosing for novel and established therapeutic modalities in oncology - invited conference talk by Fenja Klima in September.
